{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:57:16Z","timestamp":1791244636713,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016341","name":"Korea University Guro Hospital","doi-asserted-by":"publisher","award":["K2407191"],"award-info":[{"award-number":["K2407191"]}],"id":[{"id":"10.13039\/100016341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea University Medicine & Seoul Clinical Laboratories"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-23523376"],"award-info":[{"award-number":["RS-2025-23523376"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16502-4","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:54:45Z","timestamp":1783734885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and long-term treatment outcomes in childhood myelodysplastic neoplasm: a nationwide population-based study in Korea"],"prefix":"10.1186","volume":"26","author":[{"given":"Minwoong","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"16502_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1182\/asheducation-2011.1.84","volume":"2011","author":"CM Niemeyer","year":"2011","unstructured":"Niemeyer CM, Baumann I. Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematol Am Soc Hematol Educ Program. 2011;2011:84\u20139.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"16502_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2559.2011.04156.x","volume":"61","author":"I Baumann","year":"2012","unstructured":"Baumann I, F\u00fchrer M, Behrendt S, Campr V, Csomor J, Furlan I, et al. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology. 2012;61(1):10\u20137.","journal-title":"Histopathology"},{"issue":"1","key":"16502_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12185-012-1092-z","volume":"96","author":"W Yang","year":"2012","unstructured":"Yang W, Zhang P, Hama A, Ito M, Kojima S, Zhu X. Diagnosis of acquired bone marrow failure syndrome during childhood using the 2008 World Health Organization classification system. Int J Hematol. 2012;96(1):34\u20138.","journal-title":"Int J Hematol"},{"issue":"1","key":"16502_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1182\/asheducation-2016.1.598","volume":"2016","author":"H Hasle","year":"2016","unstructured":"Hasle H. Myelodysplastic and myeloproliferative disorders of childhood. Hematol Am Soc Hematol Educ Program. 2016;2016(1):598\u2013604.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"16502_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"issue":"11","key":"16502_CR6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328.","journal-title":"Blood"},{"issue":"1","key":"16502_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00428-022-03447-9","volume":"482","author":"M Rudelius","year":"2023","unstructured":"Rudelius M, Weinberg OK, Niemeyer CM, Shimamura A, Calvo KR. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia. Virchows Arch. 2023;482(1):113\u201330.","journal-title":"Virchows Arch"},{"issue":"13","key":"16502_CR8","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood-2017-09-765214","volume":"131","author":"F Locatelli","year":"2018","unstructured":"Locatelli F, Strahm B. How I treat myelodysplastic syndromes of childhood. Blood. 2018;131(13):1406\u201314.","journal-title":"Blood"},{"issue":"3","key":"16502_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cll.2021.03.015","volume":"41","author":"SS Patel","year":"2021","unstructured":"Patel SS. Pediatric Myelodysplastic Syndromes. Clin Lab Med. 2021;41(3):517\u201328.","journal-title":"Clin Lab Med"},{"issue":"Suppl 1","key":"16502_CR10","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.bmt.1704836","volume":"35","author":"J Star\u00fd","year":"2005","unstructured":"Star\u00fd J, Locatelli F, Niemeyer CM. Stem cell transplantation for aplastic anemia and myelodysplastic syndrome. Bone Marrow Transpl. 2005;35(Suppl 1):S13\u20136.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"16502_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cll.2023.06.005","volume":"43","author":"KM Chisholm","year":"2023","unstructured":"Chisholm KM, Bohling SD. Childhood Myelodysplastic Syndrome. Clin Lab Med. 2023;43(4):639\u201355.","journal-title":"Clin Lab Med"},{"issue":"11","key":"16502_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","volume":"127","author":"MW Wlodarski","year":"2016","unstructured":"Wlodarski MW, Hirabayashi S, Pastor V, Star\u00fd J, Hasle H, Masetti R, et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127(11):1387\u201397. quiz 518.","journal-title":"Blood"},{"key":"16502_CR13","doi-asserted-by":"publisher","first-page":"107563","DOI":"10.1016\/j.leukres.2024.107563","volume":"144","author":"D McCall","year":"2024","unstructured":"McCall D, Abuasab T, Rodriguez-Sevilla JJ, Mohamed SF, Patnaik A, Devireddy K, et al. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis. Leuk Res. 2024;144:107563.","journal-title":"Leuk Res"},{"issue":"7","key":"16502_CR14","doi-asserted-by":"publisher","first-page":"e13864","DOI":"10.1111\/petr.13864","volume":"24","author":"P Suo","year":"2020","unstructured":"Suo P, Wang S, Xue Y, Cheng Y, Kong J, Yan C, et al. Unmanipulated haploidentical hematopoietic stem cell transplantation for children with myelodysplastic syndrome. Pediatr Transpl. 2020;24(7):e13864.","journal-title":"Pediatr Transpl"},{"issue":"8","key":"16502_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41409-020-0814-8","volume":"55","author":"JW Yoo","year":"2020","unstructured":"Yoo JW, Im HJ, Kim H, Koh KN, Kang SH, Min SY, et al. Improved outcomes of allogeneic hematopoietic stem cell transplantation including haploidentical transplantation for childhood myelodysplastic syndrome. Bone Marrow Transpl. 2020;55(8):1595\u2013603.","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"16502_CR16","first-page":"1569","volume":"9","author":"H Hasle","year":"1995","unstructured":"Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia. 1995;9(9):1569\u201372.","journal-title":"Leukemia"},{"issue":"4","key":"16502_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1046\/j.1365-2141.1999.01645.x","volume":"106","author":"H Hasle","year":"1999","unstructured":"Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR. A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol. 1999;106(4):1027\u201332.","journal-title":"Br J Haematol"},{"issue":"5","key":"16502_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1046\/j.1365-2141.2003.04361.x","volume":"121","author":"SJ Passmore","year":"2003","unstructured":"Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol. 2003;121(5):758\u201367.","journal-title":"Br J Haematol"},{"issue":"11","key":"16502_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/MPH.0b013e3181ba43dc","volume":"31","author":"DG Aguilera","year":"2009","unstructured":"Aguilera DG, Vaklavas C, Tsimberidou AM, Wen S, Medeiros LJ, Corey SJ. Pediatric therapy-related myelodysplastic syndrome\/acute myeloid leukemia: the MD Anderson Cancer Center experience. J Pediatr Hematol Oncol. 2009;31(11):803\u201311.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"16502_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5045\/br.2016.51.4.242","volume":"51","author":"HW Cho","year":"2016","unstructured":"Cho HW, Choi YB, Yi ES, Lee JW, Sung KW, Koo HH, et al. Therapy-related myeloid neoplasms in children and adolescents. Blood Res. 2016;51(4):242\u20138.","journal-title":"Blood Res"},{"issue":"5","key":"16502_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","volume":"38","author":"SO Song","year":"2014","unstructured":"Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, et al. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014;38(5):395\u2013403.","journal-title":"Diabetes Metab J"},{"key":"16502_CR22","unstructured":"Korea Statistical Information Servive (Statistics Korea). Projected Population by Age(Korea): Korea Statistical Information Servive. https:\/\/kosis.kr\/index\/index.do."},{"issue":"2","key":"16502_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2141.2011.08724.x","volume":"154","author":"H Hasle","year":"2011","unstructured":"Hasle H, Niemeyer CM. Advances in the prognostication and management of advanced MDS in children. Br J Haematol. 2011;154(2):185\u201395.","journal-title":"Br J Haematol"},{"issue":"10","key":"16502_CR24","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","volume":"27","author":"SS Sahoo","year":"2021","unstructured":"Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A, et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes. Nat Med. 2021;27(10):1806\u201317.","journal-title":"Nat Med"},{"issue":"2","key":"16502_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/pbc.21235","volume":"50","author":"J Star\u00fd","year":"2008","unstructured":"Star\u00fd J, Baumann I, Creutzig U, Harbott J, Michalova K, Niemeyer C. Getting the numbers straight in pediatric MDS: distribution of subtypes after exclusion of down syndrome. Pediatr Blood Cancer. 2008;50(2):435\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"16502_CR26","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1200\/JCO.2003.04.100","volume":"21","author":"MC Le Deley","year":"2003","unstructured":"Le Deley MC, Leblanc T, Shamsaldin A, Raquin MA, Lacour B, Sommelet D, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique. J Clin Oncol. 2003;21(6):1074\u201381.","journal-title":"J Clin Oncol"},{"issue":"1","key":"16502_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1182\/blood-2006-01-023101","volume":"109","author":"S Bhatia","year":"2007","unstructured":"Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children\u2019s Oncology Group. Blood. 2007;109(1):46\u201351.","journal-title":"Blood"},{"issue":"10","key":"16502_CR28","doi-asserted-by":"publisher","first-page":"e28398","DOI":"10.1002\/pbc.28398","volume":"67","author":"AC Winters","year":"2020","unstructured":"Winters AC, Maloney KW, Treece AL, Gore L, Franklin AK. Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia. Pediatr Blood Cancer. 2020;67(10):e28398.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"16502_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.bmt.1705730","volume":"40","author":"B Strahm","year":"2007","unstructured":"Strahm B, Locatelli F, Bader P, Ehlert K, Kremens B, Zintl F, et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transpl. 2007;40(4):329\u201333.","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"16502_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bbmt.2010.08.016","volume":"17","author":"P Woodard","year":"2011","unstructured":"Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang MJ, et al. Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. Biol Blood Marrow Transpl. 2011;17(5):723\u20138.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"16502_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/leu.2010.297","volume":"25","author":"B Strahm","year":"2011","unstructured":"Strahm B, N\u00f6llke P, Zecca M, Korthof ET, Bierings M, Furlan I, et al. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia. 2011;25(3):455\u201362.","journal-title":"Leukemia"},{"issue":"5","key":"16502_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-2141.2012.09210.x","volume":"158","author":"A Kikuchi","year":"2012","unstructured":"Kikuchi A, Hasegawa D, Ohtsuka Y, Hamamoto K, Kojima S, Okamura J, et al. Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study. Br J Haematol. 2012;158(5):657\u201361.","journal-title":"Br J Haematol"},{"issue":"3","key":"16502_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/leu.2010.285","volume":"25","author":"AB Madureira","year":"2011","unstructured":"Madureira AB, Eapen M, Locatelli F, Teira P, Zhang MJ, Davies SM, et al. Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. Leukemia. 2011;25(3):449\u201354.","journal-title":"Leukemia"},{"issue":"11","key":"16502_CR34","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1038\/s41409-021-01374-y","volume":"56","author":"R Bortnick","year":"2021","unstructured":"Bortnick R, Wlodarski M, de Haas V, De Moerloose B, Dworzak M, Hasle H, et al. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome. Bone Marrow Transpl. 2021;56(11):2732\u201341.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"16502_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbmt.2014.12.003","volume":"21","author":"J Inagaki","year":"2015","unstructured":"Inagaki J, Fukano R, Kurauchi K, Noguchi M, Tanioka S, Okamura J. Hematopoietic stem cell transplantation in children with refractory cytopenia of childhood: single-center experience using high-dose cytarabine containing myeloablative and aplastic anemia oriented reduced-intensity conditioning regimens. Biol Blood Marrow Transpl. 2015;21(3):565\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"16502_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.hoc.2018.04.007","volume":"32","author":"MW Wlodarski","year":"2018","unstructured":"Wlodarski MW, Sahoo SS, Niemeyer CM. Monosomy 7 in Pediatric Myelodysplastic Syndromes. Hematol Oncol Clin North Am. 2018;32(4):729\u201343.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"16502_CR37","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1182\/bloodadvances.2022009253","volume":"7","author":"C Horgan","year":"2023","unstructured":"Horgan C, Mullanfiroze K, Rauthan A, Patrick K, Butt NA, Mirci-Danicar O, et al. T-cell replete cord transplants give superior outcomes in high-risk and relapsed\/refractory pediatric myeloid malignancy. Blood Adv. 2023;7(10):2155\u201365.","journal-title":"Blood Adv"},{"issue":"3","key":"16502_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbmt.2011.11.009","volume":"18","author":"R Kobos","year":"2012","unstructured":"Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, et al. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia. Biol Blood Marrow Transpl. 2012;18(3):473\u201380.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"16502_CR39","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3324\/haematol.2016.145821","volume":"101","author":"N Waespe","year":"2016","unstructured":"Waespe N, Van Den Akker M, Klaassen RJ, Lieberman L, Irwin MS, Ali SS, et al. Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantation. Haematologica. 2016;101(12):1508\u201315.","journal-title":"Haematologica"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16502-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:31:44Z","timestamp":1791243104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16502-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16502"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16502-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective nationwide cohort study was conducted following the principles of the Declaration of Helsinki. This study was approved by the Institutional Review Board of Korea University Guro Hospital, which waived the requirement for informed consent due to the use of publicly available de-identified data (2023GR0313). The study was also conducted with approval to use the NHIS database (NHIS-2024-1-524).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1191"}}